HomeCompanion AnimalsPhytoGaia’s PetGaia™ Named Pet Innovation of the Year Ahead of Vitafoods Asia

PhytoGaia’s PetGaia™ Named Pet Innovation of the Year Ahead of Vitafoods Asia

Nutraceutical developer PhytoGaia has been awarded the Pet Ingredient Innovation of the Year at the Pet Innovation Awards 2026 for its proprietary palm fruit extract, PetGaia™. The recognition comes directly ahead of the company’s scheduled presentation at Vitafoods Asia 2026 in Bangkok, where full data from a landmark randomized, double-blind, placebo-controlled trial in canine dermatological health will be presented.

PetGaia Pet Ingredient Innovation of the Year Vitafoods Asia
PetGaia Pet Ingredient Innovation of the Year Vitafoods Asia

As the only National Animal Supplement Council (NASC) preferred supplier for palm fruit extracts, PhytoGaia’s milestone reflects growing industry demand for clinically backed, clean-label botanical ingredients in companion animal health.

1. Ingredient Architecture & Bioactive Mechanism

PetGaia™ is a clean-label, non-GMO lipid extract derived from sustainably sourced palm fruits (Elaeis guineensis). It is processed using a solvent-free, non-chemical extraction technology.

Unlike conventional single-molecule vitamin E supplements, PetGaia™ provides a natural synergistic complex of lipid antioxidants:

PhytoGaia’s PetGaia™ Named Pet Ingredient Innovation
PhytoGaia’s PetGaia™ Named Pet Ingredient Innovation

Key Bioactive Components

  • Tocotrienols (“Super Vitamin E”): Possess up to 40 to 60 times higher antioxidant capacity than standard alpha-tocopherol, protecting epidermal cell membranes from UV- and pollution-induced oxidative damage.

  • Plant-Derived Squalene: Restores surface lipids to maintain skin hydration and reduce transepidermal water loss (TEWL).

  • Phytosterols: Provide targeted anti-inflammatory support, helping mitigate dermatological reactions in sensitive dogs.

2. Clinical Trial Design & Vitafoods Asia Roadmap

The award follows the completion of an 8-week randomized controlled study conducted in partnership with a clinical research organization (CRO) and led by veterinary researchers.

3. Evaluated Clinical Parameters

The trial tracked quantitative and qualitative improvements in canine skin and coat condition:

  1. Pruritus & Erythema: Reduction in itching frequency, scratching behavior, and skin redness.

  2. Coat Quality Indices: Objective improvements in coat shine, softness, and texture.

  3. Dermal Integrity: Mitigation of lesion formation and localized skin dryness.

Animal Health India Editorial Team
Animal Health India Editorial Teamhttps://animalhealthindia.com
Animal Health India (AHI) is an independent news and intelligence platform covering the global animal health, veterinary, livestock, poultry, companion animal and pet food sectors. Our editorial team comprises veterinary journalists, animal health professionals, regulatory affairs specialists and industry analysts with over 30 years of combined experience covering India, Asia, Europe and North America. AHI publishes news, regulatory updates, market intelligence and company news drawn from primary sources including DAHD, EMA, USDA, AVMA and leading veterinary publications worldwide.
RELATED ARTICLES